Antenatal Magnesium Sulfate Exposure and Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants

Objective The use of antenatal magnesium sulfate (MgSO4) has been associated with neuroprotective effects. One of its' proposed mechanisms of action includes antagonism of calcium channels. Calcium influx is important for closure of ductus arteriosus. We hypothesized that antenatal MgSO4 exposu...

Full description

Saved in:
Bibliographic Details
Main Authors: Amna Qasim (Author), Sunil K. Jain (Author), Ashraf M. Aly (Author)
Format: Book
Published: Thieme Medical Publishers, Inc., 2019-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_11e5211c148e47e496de1ce86eb24bdd
042 |a dc 
100 1 0 |a Amna Qasim  |e author 
700 1 0 |a Sunil K. Jain  |e author 
700 1 0 |a Ashraf M. Aly  |e author 
245 0 0 |a Antenatal Magnesium Sulfate Exposure and Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants 
260 |b Thieme Medical Publishers, Inc.,   |c 2019-10-01T00:00:00Z. 
500 |a 2157-6998 
500 |a 2157-7005 
500 |a 10.1055/s-0039-3400316 
520 |a Objective The use of antenatal magnesium sulfate (MgSO4) has been associated with neuroprotective effects. One of its' proposed mechanisms of action includes antagonism of calcium channels. Calcium influx is important for closure of ductus arteriosus. We hypothesized that antenatal MgSO4 exposure may be associated with an increased risk of hemodynamically significant patent ductus arteriosus (HsPDA) in premature infants (PI). Study Design A prospective cohort study conducted in two parts. PI (< 32 weeks and < 1,500 g) were recruited (n = 105). All infants had Echocardiograph (ECHO; within 3 days) and blood samples drawn at the same time for B-type natriuretic peptide (BNP; part 1) and NTproBNP (N-terminal pro BNP; part 2) measurements. HsPDA was defined as a PDA diameter > 1.5 mm and BNP levels > 40 pg/mL or NTproBNP > 10,200 pg/mL. Infants were divided into two groups based on antenatal MgSO4 exposure. Data were analyzed using SPSS 23. Difference in baseline characteristics and antenatal steroid use in the two groups was analyzed. A matched group analysis was performed to adjust for the difference in the numbers between the two groups. A p-value < 0.05 was considered significant. Results There was no significant difference seen in baseline characteristics or use of antenatal steroids in exposed versus unexposed (n = 95 vs. n = 10). There was a significant negative correlation between antenatal MgSO4 exposure and HsPDA in PI (p ≤ 0.05). However, this association was not significant after matched group analysis. Conclusion Antenatal MgSO4 exposure is not associated with an increased risk of HsPDA. It may be associated with a decreased likelihood of HsPDA. 
546 |a EN 
690 |a neonatology 
690 |a pediatric cardiology 
690 |a patent ductus arteriosus 
690 |a mgso4  
690 |a ntprobnp 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n American Journal of Perinatology Reports, Vol 09, Iss 04, Pp e353-e356 (2019) 
787 0 |n http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-3400316 
787 0 |n https://doaj.org/toc/2157-6998 
787 0 |n https://doaj.org/toc/2157-7005 
856 4 1 |u https://doaj.org/article/11e5211c148e47e496de1ce86eb24bdd  |z Connect to this object online.